| 0 (0%) | 02-21 20:16 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 164.37 | 1-year : | 174.28 |
| Resists | First : | 140.73 | Second : | 149.22 |
| Pivot price | 133.49  |
|||
| Supports | First : | 127 | Second : | 105.66 |
| MAs | MA(5) : | 133.25 |
MA(20) : | 134.77 |
| MA(100) : | 128.65 |
MA(250) : | 114.99 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 43.7 |
D(3) : | 38.1 |
| RSI | RSI(14): 50.1 |
|||
| 52-week | High : | 156 | Low : | 62.07 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ TMDX ] has closed below upper band by 43.3%. Bollinger Bands are 51.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 135.55 - 136.09 | 136.09 - 136.55 |
| Low: | 128.74 - 129.39 | 129.39 - 129.95 |
| Close: | 133.1 - 134.19 | 134.19 - 135.12 |
Sat, 21 Feb 2026
TransMedics Group Inc (NASDAQ:TMDX) Presents a Strong Growth and Technical Breakout Opportunity - ChartMill
Sat, 21 Feb 2026
King Luther Capital Management Corp Makes New $2.24 Million Investment in TransMedics Group, Inc. $TMDX - MarketBeat
Fri, 20 Feb 2026
New TransMedics hires get stock awards at $135.50 a share - Stock Titan
Thu, 19 Feb 2026
FDA Greenlights ENHANCE Heart Trial As TransMedics Valuation Draws Attention - simplywall.st
Wed, 18 Feb 2026
A Look At TransMedics Group (TMDX) Valuation After Full FDA Approval For Next Generation OCS Heart Trial - Yahoo Finance
Wed, 18 Feb 2026
What Catalysts Are Reframing The TransMedics Group (TMDX) Narrative Now - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 34 (M) |
| Shares Float | 33 (M) |
| Held by Insiders | 2.9 (%) |
| Held by Institutions | 111 (%) |
| Shares Short | 7,280 (K) |
| Shares Short P.Month | 7,000 (K) |
| EPS | 2.45 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.39 |
| Profit Margin | 16.2 % |
| Operating Margin | 16.2 % |
| Return on Assets (ttm) | 6.9 % |
| Return on Equity (ttm) | 32.4 % |
| Qtrly Rev. Growth | 32.2 % |
| Gross Profit (p.s.) | 9.99 |
| Sales Per Share | 16.57 |
| EBITDA (p.s.) | 3.52 |
| Qtrly Earnings Growth | 450.1 % |
| Operating Cash Flow | 178 (M) |
| Levered Free Cash Flow | 87 (M) |
| PE Ratio | 54.79 |
| PEG Ratio | 0 |
| Price to Book value | 12.9 |
| Price to Sales | 8.09 |
| Price to Cash Flow | 25.77 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|